Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.
NCT04483817 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2022-08-09
Summary
The main aim of this study, is compare the effectiveness of transcutaneous posterior tibial nerve stimulation versus percutaneous posterior nerve stimulation in patients with overactive bladder.
Conditions
- Overactive Bladder Syndrome
Interventions
- DEVICE
-
Transcutaneous tibial nerve stimulation
Apply tibial nerve stimulation with surface electrodes in the treatment of overactive bladder.
- DEVICE
-
Percutaneous tibial nerve stimulation
Apply tibial nerve stimulation with surface electrodes in the treatment of overactive bladder.
Sponsors & Collaborators
-
Fisiocore LC,SL
lead OTHER
Principal Investigators
-
Laura Calzado Sanz, Physiotherap · Fisiocore LC,SL
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-17
- Primary Completion
- 2023-02-01
- Completion
- 2023-09-01
Countries
- Spain
Study Locations
More Related Trials
-
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
NCT06024005 ·Status: COMPLETED ·Phase: NA
-
Overactive Bladder Innovative Therapy Trial (OrBIT)
NCT00448175 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
NCT01605617 ·Status: TERMINATED ·Phase: PHASE4
-
Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation
NCT07030803 ·Status: RECRUITING ·Phase: NA
-
Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).
NCT05211193 ·Status: COMPLETED
-
Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1
NCT06616675 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.
NCT00481728 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
NCT04113941 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01604928 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder
NCT00224146 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity
NCT00800462 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
NCT00444925 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
NCT00768521 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
NCT00224016 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
NCT02240459 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
NCT00139724 ·Status: COMPLETED ·Phase: PHASE3
-
InSite for Over Active Bladder
NCT00547378 ·Status: COMPLETED ·Phase: PHASE4
-
Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol
NCT03559946 ·Status: TERMINATED ·Phase: NA
-
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
NCT05188742 ·Status: UNKNOWN ·Phase: PHASE4
-
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)
NCT00231790 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder
NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
NCT01558856 ·Status: COMPLETED ·Phase: NA
-
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder
NCT00928070 ·Status: COMPLETED ·Phase: PHASE4